We Backed Archer Aviation Over Joby Aviation a Year Ago. Here's Why We Were Wrong.

The market has stopped rewarding “best technology path” and is instead pricing the first company that can convert regulatory progress into commercial credibility. That shift matters because eVTOL is no longer a binary certification trade; it is a working-capital and go-to-market race, where visible revenue reduces financing risk and compresses the discount rate more than marginal improvements in FAA milestones. The second-order effect is that capital is migrating toward the name that can keep raising on better terms, while the other becomes increasingly hostage to dilution, even if its technical execution is cleaner.

Joby’s new role is less “science project” and more “option on a transportation network,” which creates a much more defensible multiple over the next 6-12 months. If management can keep converting small operational wins into recurring revenue and route density, the stock should trade on forward bookings and cash burn slope, not historical skepticism about certification. Archer, by contrast, risks becoming a classic late-stage pre-revenue story where each positive headline is met with selling because the market now assumes equity issuance is the default funding source.

The contrarian read is that Archer’s defense optionality may be underappreciated in a zero-to-one civilian adoption model, but that catalyst is likely years away and insensitive to near-term sentiment. The more immediate upside in the sector may actually come from the ancillary beneficiaries: lessors, aerospace suppliers, airport infrastructure partners, and strategic backers that can monetize optionality without underwriting the full balance-sheet risk. If macro rates stabilize, the group could re-rate, but until then the cleanest signal is revenue visibility versus certification optics.

The main risk to the current setup is that Joby’s revenue step-up proves lumpy or non-recurring, which would quickly re-open the dilution debate and compress the valuation back toward Archer-like levels. Conversely, any new Archer capital raise or missed commercialization deadline would likely trigger a fast multiple reset over days, not months, because the stock is already being judged on funding durability rather than engineering progress.